Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT00766116
Status:
COMPLETED
Last Update Posted:
2019-02-18
First Post:
2008-10-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-02
First Submit QC Date:
None
Study First Post Date:
2008-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-29
Results First Submit QC Date:
None
Results First Post Date:
2019-02-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-02-18
Last Update Post Date Type:
ACTUAL